Advertisement
Screener

LIFECORE BIOMEDICAL, INC. (LFCR) Capital Expenditures

2.8 / 5 stars · 68/120 Roast Me

LIFECORE BIOMEDICAL, INC. Capital Expenditures

LIFECORE BIOMEDICAL, INC. (LFCR) reported Capital Expenditures of $1.63 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Cash Flow › Investing Activities

us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-05

  • LIFECORE BIOMEDICAL, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $513.00K.
  • LIFECORE BIOMEDICAL, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $1.12M.
  • LIFECORE BIOMEDICAL, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $1.74M.
  • LIFECORE BIOMEDICAL, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-05-25 was $2.10M, a 22.71% decline year-over-year.
  • LIFECORE BIOMEDICAL, INC. payments to acquire property, plant, and equipment for fiscal 2025 was $13.41M, a 27.07% decline from fiscal 2024.
  • LIFECORE BIOMEDICAL, INC. payments to acquire property, plant, and equipment for fiscal 2024 was $18.39M.
  • LIFECORE BIOMEDICAL, INC. payments to acquire property, plant, and equipment for fiscal 2022 was $26.23M, a 36.14% increase from fiscal 2021.
  • LIFECORE BIOMEDICAL, INC. payments to acquire property, plant, and equipment for fiscal 2021 was $19.26M, a 57.72% increase from fiscal 2020.
Period endPayments to Acquire Property, Plant, and Equipment 3 monthPayments to Acquire Property, Plant, and Equipment 3 month as first filedPayments to Acquire Property, Plant, and Equipment 6 monthPayments to Acquire Property, Plant, and Equipment 6 month as first filedPayments to Acquire Property, Plant, and Equipment 7 monthPayments to Acquire Property, Plant, and Equipment 9 monthPayments to Acquire Property, Plant, and Equipment 9 month as first filedPayments to Acquire Property, Plant, and Equipment 12 monthPayments to Acquire Property, Plant, and Equipment 12 month as first filed
2026-06-30$513.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
$1.63M
10-Q · filed 2026-08-05
2026-03-31$1.12M
10-Q · filed 2026-05-06
2025-12-31$3.70M
10-KT · filed 2026-03-16
2025-09-30$1.74M
10-Q · filed 2025-11-06
2025-05-25$2.10M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
$7.55M
10-Q · filed 2026-08-05
$9.99M
derived: sum of 3 quarters · filed 2026-08-05
$13.41M
10-KT · filed 2026-03-16
2025-02-23$5.46M
10-Q · filed 2026-05-06
$7.90M
derived: sum of 2 quarters · filed 2026-05-06
$11.32M
10-Q · filed 2025-04-03
$14.03M
derived: sum of 4 quarters · filed 2026-05-06
2024-11-24$2.44M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-01-02
$5.86M
10-Q · filed 2025-01-02
$8.57M
derived: sum of 3 quarters · filed 2026-03-16
$14.94M
derived: sum of 4 quarters · filed 2026-03-16
2024-08-25$3.42M
10-Q · filed 2025-11-06
$3.39M
10-Q · filed 2024-10-04
$6.13M
derived: sum of 2 quarters · filed 2026-03-16
$12.50M
derived: sum of 3 quarters · filed 2026-03-16
$16.76M
derived: sum of 4 quarters · filed 2026-03-16
2024-05-26$2.71M
derived: 10-KT 12 month − 10-Q 9 month · filed 2026-03-16
$9.08M
derived: sum of 2 quarters · filed 2026-03-16
$13.34M
derived: sum of 3 quarters · filed 2026-03-16
$18.39M
10-KT · filed 2026-03-16
2024-02-25$6.37M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-04-03
$10.63M
derived: sum of 2 quarters · filed 2025-04-03
$15.68M
10-Q · filed 2025-04-03
$15.28M
10-Q · filed 2024-08-09
2023-11-26$4.26M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-01-02
$9.31M
10-Q · filed 2025-01-02
$9.03M
10-Q · filed 2024-08-09
2023-08-27$5.05M
10-Q · filed 2024-10-04
2023-02-26$7.10M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-09
$10.95M
derived: sum of 2 quarters · filed 2024-08-09
$14.31M
10-Q · filed 2024-08-09
$12.32M
10-Q · filed 2023-06-02
$22.00M
derived: sum of 4 quarters · filed 2024-08-09
2022-11-27$3.85M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09
$7.21M
10-Q · filed 2024-08-09
$6.18M
10-Q · filed 2023-03-16
$14.90M
derived: sum of 3 quarters · filed 2024-08-09
$20.43M
derived: sum of 4 quarters · filed 2024-08-09
2022-08-28$3.36M
10-Q · filed 2024-08-09
$2.93M
10-Q · filed 2022-10-07
$11.05M
derived: sum of 2 quarters · filed 2024-08-09
$16.58M
derived: sum of 3 quarters · filed 2024-08-09
$21.67M
derived: sum of 4 quarters · filed 2024-08-09
2022-05-29$7.69M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-16
$13.22M
derived: sum of 2 quarters · filed 2023-06-02
$18.31M
derived: sum of 3 quarters · filed 2023-06-02
$26.23M
10-K/A · filed 2023-03-16
2022-02-27$5.53M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-06-02
$10.63M
derived: sum of 2 quarters · filed 2023-06-02
$18.54M
10-Q · filed 2023-06-02
$26.42M
derived: sum of 4 quarters · filed 2023-06-02
2021-11-28$5.10M
derived: 10-Q 6 month − 10-Q/A 3 month · filed 2023-03-16
$13.01M
10-Q · filed 2023-03-16
$20.89M
derived: sum of 3 quarters · filed 2023-03-16
$24.87M
derived: sum of 4 quarters · filed 2023-03-16
2021-08-29$7.91M
10-Q/A · filed 2023-03-16
$15.79M
derived: sum of 2 quarters · filed 2023-03-16
$19.77M
derived: sum of 3 quarters · filed 2023-03-16
$22.55M
derived: sum of 4 quarters · filed 2023-03-16
2021-05-30$7.88M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-16
$11.86M
derived: sum of 2 quarters · filed 2023-03-16
$14.64M
derived: sum of 3 quarters · filed 2023-03-16
$19.26M
10-K/A · filed 2023-03-16
$23.77M
10-K · filed 2021-07-29
2021-02-28$3.98M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-04-07
$6.76M
derived: sum of 2 quarters · filed 2022-04-07
$11.38M
10-Q · filed 2022-04-07
$1.48M
derived: sum of 4 quarters · filed 2023-03-16
2020-11-29$2.78M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-01-07
$7.41M
10-Q · filed 2022-01-07
-$2.50M
derived: sum of 3 quarters · filed 2023-03-16
$3.59M
derived: sum of 4 quarters · filed 2023-03-16
2020-08-30$4.62M
10-Q · filed 2021-10-05
-$5.28M
derived: sum of 2 quarters · filed 2023-03-16
$808.00K
derived: sum of 3 quarters · filed 2023-03-16
$6.86M
derived: sum of 4 quarters · filed 2023-03-16
2020-05-31-$9.90M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-16
-$3.81M
derived: sum of 2 quarters · filed 2023-03-16
$2.23M
derived: sum of 3 quarters · filed 2023-03-16
$12.21M
10-K/A · filed 2023-03-16
$26.69M
10-K · filed 2020-08-14
2020-02-23$6.09M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-04-08
$12.14M
derived: sum of 2 quarters · filed 2021-04-08
$22.12M
10-Q · filed 2021-04-08
$33.71M
derived: sum of 4 quarters · filed 2021-07-29
2019-11-24$6.05M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-01-07
$16.03M
10-Q · filed 2021-01-07
$27.62M
derived: sum of 3 quarters · filed 2021-07-29
$42.17M
derived: sum of 4 quarters · filed 2021-07-29
2019-08-25$9.98M
10-Q · filed 2020-10-07
$21.57M
derived: sum of 2 quarters · filed 2021-07-29
$36.13M
derived: sum of 3 quarters · filed 2021-07-29
$40.27M
derived: sum of 4 quarters · filed 2021-07-29
2019-05-26$11.59M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-29
$26.15M
derived: sum of 2 quarters · filed 2021-07-29
$30.29M
derived: sum of 3 quarters · filed 2021-07-29
$44.73M
10-K · filed 2021-07-29
2019-02-24$14.56M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-04-03
$18.70M
derived: sum of 2 quarters · filed 2020-04-03
$33.14M
10-Q · filed 2020-04-03
$46.00M
derived: sum of 4 quarters · filed 2020-08-14
2018-11-25$4.15M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-01-02
$18.59M
10-Q · filed 2020-01-02
$31.44M
derived: sum of 3 quarters · filed 2020-08-14
$42.74M
derived: sum of 4 quarters · filed 2020-08-14
2018-08-26$14.44M
10-Q · filed 2019-10-03
$27.30M
derived: sum of 2 quarters · filed 2020-08-14
$38.59M
derived: sum of 3 quarters · filed 2020-08-14
$42.30M
derived: sum of 4 quarters · filed 2020-08-14
2018-05-27$12.86M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-14
$24.15M
derived: sum of 2 quarters · filed 2020-08-14
$27.86M
derived: sum of 3 quarters · filed 2020-08-14
$33.59M
10-K · filed 2020-08-14
2018-02-25$11.30M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-04-04
$15.01M
derived: sum of 2 quarters · filed 2019-04-04
$20.73M
10-Q · filed 2019-04-04
$18.53M
10-Q · filed 2018-04-05
$34.25M
derived: sum of 4 quarters · filed 2019-08-01
2017-11-26$3.71M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-01-07
$9.44M
10-Q · filed 2019-01-07
$7.43M
10-Q · filed 2018-01-05
$22.95M
derived: sum of 3 quarters · filed 2019-08-01
$27.70M
derived: sum of 4 quarters · filed 2019-08-01
2017-08-27$5.73M
10-Q · filed 2018-10-05
$2.15M
10-Q · filed 2017-09-28
$19.24M
derived: sum of 2 quarters · filed 2019-08-01
$23.99M
derived: sum of 3 quarters · filed 2019-08-01
$26.60M
derived: sum of 4 quarters · filed 2019-08-01
2017-05-28$13.52M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-01
$18.27M
derived: sum of 2 quarters · filed 2019-08-01
$20.87M
derived: sum of 3 quarters · filed 2019-08-01
$23.00M
10-K · filed 2019-08-01
$22.59M
10-K · filed 2017-08-11
2017-02-26$4.75M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-04-05
$7.36M
derived: sum of 2 quarters · filed 2018-04-05
$9.49M
10-Q · filed 2018-04-05
$23.02M
derived: sum of 4 quarters · filed 2018-08-09
2016-11-27$2.61M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-01-05
$4.74M
10-Q · filed 2018-01-05
$18.27M
derived: sum of 3 quarters · filed 2018-08-09
$29.23M
derived: sum of 4 quarters · filed 2018-08-09
2016-08-28$2.13M
10-Q · filed 2017-09-28
$15.67M
derived: sum of 2 quarters · filed 2018-08-09
$26.62M
derived: sum of 3 quarters · filed 2018-08-09
$38.34M
derived: sum of 4 quarters · filed 2018-08-09
2016-05-29$13.54M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-09
$24.49M
derived: sum of 2 quarters · filed 2018-08-09
$36.21M
derived: sum of 3 quarters · filed 2018-08-09
$39.70M
10-K · filed 2018-08-09
$40.87M
10-K · filed 2016-08-01
2016-02-28$10.96M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-04-07
$22.67M
derived: sum of 2 quarters · filed 2017-04-07
$26.16M
10-Q · filed 2017-04-07
$33.47M
derived: sum of 4 quarters · filed 2018-03-15
2015-11-29$11.72M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-01-05
$15.20M
10-Q · filed 2017-01-05
$22.51M
derived: sum of 3 quarters · filed 2018-03-15
$25.58M
derived: sum of 4 quarters · filed 2018-03-15
2015-08-30$3.49M
10-Q · filed 2016-09-29
$10.80M
derived: sum of 2 quarters · filed 2018-03-15
$13.86M
derived: sum of 3 quarters · filed 2018-03-15
$16.90M
derived: sum of 4 quarters · filed 2018-03-15
2015-05-31$7.31M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2018-03-15
$10.38M
derived: sum of 2 quarters · filed 2018-03-15
$13.41M
derived: sum of 3 quarters · filed 2018-03-15
$17.51M
10-K/A · filed 2018-03-15
2015-03-01$3.07M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-03-30
$6.10M
derived: sum of 2 quarters · filed 2016-03-30
$10.20M
10-Q · filed 2016-03-30
$14.90M
derived: sum of 4 quarters · filed 2016-08-01
2014-11-30$3.04M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-01-07
$7.13M
10-Q · filed 2016-01-07
$11.83M
derived: sum of 3 quarters · filed 2016-08-01
$14.34M
derived: sum of 4 quarters · filed 2016-08-01
2014-08-31$4.10M
10-Q · filed 2015-10-01
$8.79M
derived: sum of 2 quarters · filed 2016-08-01
$11.30M
derived: sum of 3 quarters · filed 2016-08-01
$14.64M
derived: sum of 4 quarters · filed 2016-08-01
2014-05-25$4.69M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-01
$7.21M
derived: sum of 2 quarters · filed 2016-08-01
$10.54M
derived: sum of 3 quarters · filed 2016-08-01
$14.89M
10-K · filed 2016-08-01
2014-02-23$2.51M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-02
$5.85M
derived: sum of 2 quarters · filed 2015-04-02
$10.19M
10-Q · filed 2015-04-02
$14.53M
derived: sum of 4 quarters · filed 2015-04-02
2013-11-24$3.34M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-01-09
$7.68M
10-Q · filed 2015-01-09
$12.02M
derived: sum of 3 quarters · filed 2015-01-09
2013-08-25$4.34M
10-Q · filed 2014-10-08
$8.68M
derived: sum of 2 quarters · filed 2014-10-08
2013-05-28$4.34M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-01
$8.88M
10-K · filed 2014-08-01
2013-05-26$4.34M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-31
$5.60M
derived: sum of 2 quarters · filed 2015-07-31
$6.85M
derived: sum of 3 quarters · filed 2015-07-31
$8.88M
10-K · filed 2015-07-31
2013-02-24$1.26M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-28
$2.51M
derived: sum of 2 quarters · filed 2014-03-28
$4.54M
10-Q · filed 2014-03-28
$6.02M
derived: sum of 4 quarters · filed 2014-08-01
2012-11-25$1.25M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-01-03
$3.28M
10-Q · filed 2014-01-03
$4.76M
derived: sum of 3 quarters · filed 2014-08-01
$5.61M
derived: sum of 4 quarters · filed 2014-08-01
2012-08-26$2.03M
10-Q · filed 2013-09-26
$3.51M
derived: sum of 2 quarters · filed 2014-08-01
$4.36M
derived: sum of 3 quarters · filed 2014-08-01
$5.84M
derived: sum of 4 quarters · filed 2014-08-01
2012-05-27$1.48M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-01
$2.33M
derived: sum of 2 quarters · filed 2014-08-01
$3.81M
derived: sum of 3 quarters · filed 2014-08-01
$5.37M
10-K · filed 2014-08-01
2012-02-26$850.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-04-04
$2.33M
derived: sum of 2 quarters · filed 2013-04-04
$3.89M
10-Q · filed 2013-04-04
$5.70M
derived: sum of 4 quarters · filed 2013-08-07
2011-11-27$1.48M
derived: 10-Q 6 month − 10-Q/A 3 month · filed 2013-01-04
$3.04M
10-Q · filed 2013-01-04
$4.85M
derived: sum of 3 quarters · filed 2013-08-07
2011-08-28$1.56M
10-Q/A · filed 2013-01-02
$3.37M
derived: sum of 2 quarters · filed 2013-08-07
2011-05-29$1.81M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-07
$6.68M
10-K · filed 2013-08-07
2011-02-27$4.88M
10-Q · filed 2012-03-28
2010-11-28$3.45M
10-Q · filed 2012-01-05
2010-08-29$1.68M
10-Q · filed 2011-10-05
2010-05-30$5.19M
10-K · filed 2012-08-08

Similar stocks

Stock NameCountryMarket CapPE Ratio
ADC Therapeutics SA (ADCT)$0.163B-1.39
Minerva Neurosciences, Inc. (NERV)United States$0.165B-0.66
Tonix Pharmaceuticals Holding Corp. (TNXP)United States$0.166B-1.34
Annexon, Inc. (ANNX)United States$0.147B-4.22
Corbus Pharmaceuticals Holdings, Inc. (CRBP)United States$0.144B-1.72
Organogenesis Holdings Inc. (ORGO)United States$0.182B-3.70
SPRUCE BIOSCIENCES, INC. (SPRB)United States$0.142B-2.89
Korro Bio, Inc. (KRRO)United States$0.141B-1.81
AN2 Therapeutics, Inc. (ANTX)United States$0.185B-4.84
Atrium Therapeutics, Inc. (RNA)United States$0.140B